95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
61.12%
Positive revenue growth while NEM is negative. John Neff might see a notable competitive edge here.
80.95%
Gross profit growth above 1.5x NEM's 14.51%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
49.00%
EBIT growth above 1.5x NEM's 3.43%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
49.00%
Operating income growth above 1.5x NEM's 3.43%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
77.62%
Net income growth above 1.5x NEM's 51.21%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
157.14%
EPS growth above 1.5x NEM's 51.38%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
157.14%
Diluted EPS growth above 1.5x NEM's 54.21%. David Dodd would see if there's a robust moat protecting these shareholder gains.
2.51%
Slight or no buybacks while NEM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.79%
Slight or no buyback while NEM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
76.90%
Positive OCF growth while NEM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
56.72%
Positive FCF growth while NEM is negative. John Neff would see a strong competitive edge in net cash generation.
111913529.36%
10Y revenue/share CAGR above 1.5x NEM's 77.35%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
347.36%
5Y revenue/share CAGR above 1.5x NEM's 80.03%. David Dodd would look for consistent product or market expansions fueling outperformance.
88.39%
3Y revenue/share CAGR 1.25-1.5x NEM's 77.46%. Bruce Berkowitz might see better product or regional expansions than the competitor.
56378.70%
10Y OCF/share CAGR above 1.5x NEM's 29.82%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
751.37%
5Y OCF/share CAGR above 1.5x NEM's 58.92%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
129.26%
3Y OCF/share CAGR above 1.5x NEM's 16.12%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1226663.69%
Net income/share CAGR above 1.5x NEM's 2838.37% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
816.94%
5Y net income/share CAGR at 75-90% of NEM's 1087.23%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
212.66%
3Y net income/share CAGR 50-75% of NEM's 358.70%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
347.46%
5Y equity/share CAGR above 1.5x NEM's 44.43%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
82.95%
3Y equity/share CAGR 1.25-1.5x NEM's 62.79%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.10%
Firm’s AR is declining while NEM shows 15.12%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
11.48%
Asset growth above 1.5x NEM's 5.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.57%
1.25-1.5x NEM's 8.46%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-6.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
29.55%
We expand SG&A while NEM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.